Loading provider…
Loading provider…
Hematology & Oncology Physician in Sacramento, CA
NPI: 1326324575Primary Practice Location
UNIVERSITY OF CALIFORNIA DAVIS MEDICAL CENTER
4301 X St, Sacramento, CA
Primary Employer
UC Davis Health Intergrative Medicine
health.ucdavis.edu
HQ Phone
Get M.D. Helen's Phone Numberphone_androidMobile
Get M.D. Helen's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2011 - 2027

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
University of California Davis Health
Fellowship • Hematology and Medical Oncology
2013 - 2016
Alameda Health System-Highland Hospital
Residency • Internal Medicine
2009 - 2012
St. George's University School of Medicine
Medical School
Until 2008
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 199 | 335 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 145 | 327 |
| 3 | 99443Physician telephone patient service, 21-30 minutes of medical discussion | 38 | 65 |
| 4 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 27 | 144 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 14 | 14 |
Newborn Screening for Cystic Fibrosis in California
A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancer.
Authors: Primo Lara, Paramita Ghosh, Stanley Yap, Marc Dall'Era, Christopher Evans
Journal: Cancer
Publication Date: 2016-03-28
Authors: Tianhong Li, David Richman, Ricardo Maselli, Richard Young, Ge Xiong, Emanual Maverakis
Journal: Front Oncol
Publication Date: 2023-07-03
Lead Sponsor: Eli Lilly and Company
Collaborators: NSABP Foundation Inc
Intervention / Treatment: DRUG: Abemaciclib, DRUG: Standard Adjuvant Endocrine Therapy